Myers Scott Dunseth

FollowCreate a free account to set a filing alert.

Senior Vice President at Euthymics Bioscience, Inc. · on record since Jun 30, 2006
Director at Zentalis Pharmaceuticals, Inc. · on record since Nov 13, 2024
Director at CASCADE CORP · on record since Jun 28, 2016
President and CEO at CASCADE CORP · on record since Jun 28, 2016
Director at Cascadian Therapeutics, Inc. · on record since Apr 6, 2016
President and CEO at Cascadian Therapeutics, Inc. · on record since Apr 6, 2016
Director at Trillium Therapeutics Inc. · on record since May 5, 2021
Director at Harpoon Therapeutics, Inc. · on record since Feb 7, 2019
Director at Cartesian Therapeutics, Inc. · on record since Jun 18, 2019
Director at AMAG PHARMACEUTICALS, INC. · on record since Apr 30, 2020
President & CEO at AMAG PHARMACEUTICALS, INC. · on record since Apr 30, 2020
Director at DYNAVAX TECHNOLOGIES CORP · on record since Oct 21, 2021
Director at Viridian Therapeutics, Inc.\DE · on record since Mar 13, 2023
Chief Executive Officer at Viridian Therapeutics, Inc.\DE · on record since Mar 13, 2023

Insider trading activity of Myers Scott Dunseth

Transactions on record: 86; since May 26, 2006

Purchases: 13; $582K

Sales: 0

Companies traded: 10; last filing Jun 18, 2026

Figures computed from official regulatory filings — .

Companies where Myers Scott Dunseth has traded

Zentalis Pharmaceuticals, Inc.4 tx · $29.4K · Jun 18, 2026
DYNAVAX TECHNOLOGIES CORP18 tx · $41.1K · Feb 10, 2026
15 tx · Mar 11, 2024
13 tx · $216.5K · Nov 15, 2023
4 tx · $261.8K · Apr 12, 2023
2 tx · Nov 19, 2021
2 tx · Nov 17, 2020
24 tx · $236.2K · Mar 13, 2018
1 tx · Apr 6, 2016
3 tx · $130.9K · Jun 30, 2006

Track record of Myers Scott Dunseth

Statistical track record

Free account

Purchases: 13

Last buy: Aug 22, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Myers Scott Dunseth

Co-insiders of Myers Scott Dunseth

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Zentalis Pharmaceuticals, Inc.Listing on record	Jun 18, 2026	Award	57,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-28,500	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-45,000	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	Other	-31,204	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	Other	-3,800	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-16,875	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-22,500	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-22,500	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Aug 25, 2025	Buy	3,800	10.82 USD	$41.1K	conv 30	SEC
Zentalis Pharmaceuticals, Inc.Listing on record	Jun 18, 2025	Award	57,603	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Jun 13, 2025	AwardD (derivative)	28,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Jun 13, 2025	Award	5,758	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zentalis Pharmaceuticals, Inc.Listing on record	Apr 30, 2025	Buy	21,000	1.40 USD	$29.4K	conv 54ClusterFirst in 12mo	SEC
Zentalis Pharmaceuticals, Inc.Listing on record	Nov 13, 2024	Award	260,192	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	May 28, 2024	Award	5,357	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	May 28, 2024	AwardD (derivative)	22,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Harpoon Therapeutics, Inc.Listing unverified	Mar 11, 2024	OtherD (derivative)	-2,033	—	n/a (No price was disclosed in the filing)		SEC
Harpoon Therapeutics, Inc.Listing unverified	Mar 11, 2024	OtherD (derivative)	-4,600	—	n/a (No price was disclosed in the filing)		SEC
Harpoon Therapeutics, Inc.Listing unverified	Mar 11, 2024	Other	-22,665	—	n/a (No price was disclosed in the filing)		SEC
Harpoon Therapeutics, Inc.Listing unverified	Jan 3, 2024	Award	2,048	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Harpoon Therapeutics, Inc.Listing unverified	Nov 28, 2023	Award	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cartesian Therapeutics, Inc.Listing on record	Nov 15, 2023	OtherD (derivative)	-87,500	0.93 USD	$81.4K		SEC
Cartesian Therapeutics, Inc.Listing on record	Nov 15, 2023	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)		SEC
Cartesian Therapeutics, Inc.Listing on record	Nov 15, 2023	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)		SEC
Cartesian Therapeutics, Inc.Listing on record	Nov 15, 2023	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Zentalis Pharmaceuticals, Inc.Listing on record	Jun 18, 2026	Award	57,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-28,500	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-45,000	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	Other	-31,204	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	Other	-3,800	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-16,875	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-22,500	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Feb 10, 2026	OtherD (derivative)	-22,500	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Aug 25, 2025	Buy	3,800	10.82 USD	$41.1K	conv 30	SEC
Zentalis Pharmaceuticals, Inc.Listing on record	Jun 18, 2025	Award	57,603	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Jun 13, 2025	AwardD (derivative)	28,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	Jun 13, 2025	Award	5,758	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zentalis Pharmaceuticals, Inc.Listing on record	Apr 30, 2025	Buy	21,000	1.40 USD	$29.4K	conv 54ClusterFirst in 12mo	SEC
Zentalis Pharmaceuticals, Inc.Listing on record	Nov 13, 2024	Award	260,192	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	May 28, 2024	Award	5,357	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	May 28, 2024	AwardD (derivative)	22,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Harpoon Therapeutics, Inc.Listing unverified	Mar 11, 2024	OtherD (derivative)	-2,033	—	n/a (No price was disclosed in the filing)		SEC
Harpoon Therapeutics, Inc.Listing unverified	Mar 11, 2024	OtherD (derivative)	-4,600	—	n/a (No price was disclosed in the filing)		SEC
Harpoon Therapeutics, Inc.Listing unverified	Mar 11, 2024	Other	-22,665	—	n/a (No price was disclosed in the filing)		SEC
Harpoon Therapeutics, Inc.Listing unverified	Jan 3, 2024	Award	2,048	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Harpoon Therapeutics, Inc.Listing unverified	Nov 28, 2023	Award	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cartesian Therapeutics, Inc.Listing on record	Nov 15, 2023	OtherD (derivative)	-87,500	0.93 USD	$81.4K		SEC
Cartesian Therapeutics, Inc.Listing on record	Nov 15, 2023	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)		SEC
Cartesian Therapeutics, Inc.Listing on record	Nov 15, 2023	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)		SEC
Cartesian Therapeutics, Inc.Listing on record	Nov 15, 2023	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC